These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26292877)

  • 1. Re: Is Type-2 Diabetes Mellitus Associated with Overactive Bladder Symptoms in Men with Lower Urinary Tract Symptoms?
    Kaplan SA
    J Urol; 2015 Sep; 194(3):736. PubMed ID: 26292877
    [No Abstract]   [Full Text] [Related]  

  • 2. Is type-2 diabetes mellitus associated with overactive bladder symptoms in men with lower urinary tract symptoms?
    Bang WJ; Lee JY; Koo KC; Hah YS; Lee DH; Cho KS
    Urology; 2014 Sep; 84(3):670-4. PubMed ID: 25168549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation Between Advanced Glycation End-Products, Lower Urinary Tract Symptoms and Bladder Dysfunctions in Patients with type 2 Diabetes Mellitus.
    Galì A; Mucciardi G; Butticè S; Subba E; D'Amico C; Lembo F; Magno C
    Low Urin Tract Symptoms; 2017 Jan; 9(1):15-20. PubMed ID: 28120449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The coexistence of interstitial cystitis and overactive bladder in a patient with lower urinary tract symptoms.
    Tsai CP; Cheng KL; Liu CK; Chou MM; Chen GD; Hung MJ
    Taiwan J Obstet Gynecol; 2014 Jun; 53(2):263-6. PubMed ID: 25017283
    [No Abstract]   [Full Text] [Related]  

  • 5. Defining the role of overactive bladder treatments in men with lower urinary tract symptoms.
    Lemack GE
    Nat Clin Pract Urol; 2007 Apr; 4(4):174-5. PubMed ID: 17415351
    [No Abstract]   [Full Text] [Related]  

  • 6. Association of increased urine brain derived neurotrophic factor with lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Wang LW; Li JL; Yu Y; Xiao RH; Huang HW; Kuang RR; Hai B
    J Huazhong Univ Sci Technolog Med Sci; 2017 Aug; 37(4):531-535. PubMed ID: 28786061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is benign prostatic obstruction surgery indicated for improving overactive bladder symptoms in men with lower urinary tract symptoms?
    Cornu JN; Grise P
    Curr Opin Urol; 2016 Jan; 26(1):17-21. PubMed ID: 26574877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower urinary tract symptoms (LUTS) in men: thinking beyond the prostate.
    Elsamra S; Ellsworth PS
    Med Health R I; 2010 Feb; 93(2):53-6. PubMed ID: 20329627
    [No Abstract]   [Full Text] [Related]  

  • 9. Estimating the quality-of-life impact and cost-effectiveness of alpha-blocker and anti-muscarinic combination treatment in men with lower urinary tract symptoms related to benign prostatic hyperplasia and overactive bladder.
    Verheggen BG; Lee R; Lieuw On MM; Treur MJ; Botteman MF; Kaplan SA; Trocio JN
    J Med Econ; 2012; 15(3):586-600. PubMed ID: 22332704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The practical update for family physicians in the diagnosis and management of overactive bladder and lower urinary tract symptoms.
    Barkin J; Habert J; Wong A; Lee LYT
    Can J Urol; 2017 Oct; 24(5S1):1-11. PubMed ID: 29151006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial combined treatment with anticholinergics and α-blockers for men with lower urinary tract symptoms related to BPH and overactive bladder: a prospective, randomized, multi-center, double-blind, placebo-controlled study.
    Lee SH; Chung BH; Kim SJ; Kim JH; Kim JC; Lee JY
    Prostate Cancer Prostatic Dis; 2011 Dec; 14(4):320-5. PubMed ID: 21788967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation and validation of the core lower urinary tract symptom score as an outcome assessment tool for the treatment of benign prostatic hyperplasia: effects of the α1-adrenoreceptor antagonist silodosin.
    Ito H; Sano F; Ogawa T; Yao M
    Int J Urol; 2014 Jan; 21(1):108-12. PubMed ID: 23662900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overactive bladder (OAB): A symptom in search of a disease - Its relationship to specific lower urinary tract symptoms and conditions.
    Van Batavia JP; Combs AJ; Fast AM; Glassberg KI
    J Pediatr Urol; 2017 Jun; 13(3):277.e1-277.e4. PubMed ID: 28527720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Association of lower urinary tract symptoms and testosterone deficiency in men with type 2 diabetes].
    Kogan MI; Belousov II; Ibishev HS; Cherniy AA; Khripun IA; Vorobyev SV; Sizjakin DV
    Urologiia; 2016 Dec; (6):22-26. PubMed ID: 28248039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term safety and efficacy of single-tablet combinations of solifenacin and tamsulosin oral controlled absorption system in men with storage and voiding lower urinary tract symptoms: results from the NEPTUNE Study and NEPTUNE II open-label extension.
    Drake MJ; Chapple C; Sokol R; Oelke M; Traudtner K; Klaver M; Drogendijk T; Van Kerrebroeck P;
    Eur Urol; 2015 Feb; 67(2):262-70. PubMed ID: 25070148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of brainderived neurotrophic factor in urine of patients with benign prostatic hyperplasia complicated overactive bladder symptoms].
    Hu H; Xu KX; Zhang XP; Fang ZW; Chen JW; Huo F; Wang D; Wang XF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Aug; 46(4):519-23. PubMed ID: 25131461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Add-on fesoterodine for residual storage symptoms suggestive of overactive bladder in men receiving α-blocker treatment for lower urinary tract symptoms.
    Kaplan SA; Roehrborn CG; Gong J; Sun F; Guan Z
    BJU Int; 2012 Jun; 109(12):1831-40. PubMed ID: 21966995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of short-term overactive bladder symptom improvement after transurethral resection of prostate in men with benign prostatic obstruction.
    Zhao YR; Liu WZ; Guralnick M; Niu WJ; Wang Y; Sun G; Xu Y
    Int J Urol; 2014 Oct; 21(10):1035-40. PubMed ID: 24825248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solifenacin/tamsulosin fixed-dose combination therapy to treat lower urinary tract symptoms in patients with benign prostatic hyperplasia.
    Dimitropoulos K; Gravas S
    Drug Des Devel Ther; 2015; 9():1707-16. PubMed ID: 25834406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into the development of a new index, vesical adaptation response to diuresis, for understanding lower urinary tract dysfunction.
    Matsuoka K; Akaihta H; Hata J; Imai H; Tanji R; Honda-Takinami R; Hoshi S; Koguchi T; Sato Y; Kataoka M; Ogawa S; Kojima Y
    Int J Urol; 2022 Apr; 29(4):297-303. PubMed ID: 34923694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.